Life Sciences
What It Feels Like to Wait for a Treatment That Doesn’t Exist
One patient’s journey through rare disease diagnosis, clinical trial participation,…
Accessibility in Clinical Trials Isn’t Optional. It’s Foundational to Better Recruitment.
Patient recruitment has always been one of the most challenging…
EMA’s Guiding Principles on LLMs: Reshaping Regulatory Translation
Discover how the EMA’s Guiding Principles on LLMs are transforming…
Creating a Future-Ready Model for a Global MedTech Leader
Discover how a global MedTech leader deployed OPAL Enable to…
How FDA and EMA Shape Linguistic Validation in Clinical Research
As clinical research becomes global, understanding how to meet regulatory…
EUDAMED and the New Reality for Medical Device Companies
What increased transparency means for post-market surveillance and multilingual compliance.
From Pressure to Possibility: Key Insights from our MedTech Roundtable
Anja Schaefer, Global Head of Commercial for Welo Life Sciences,…
The Silent Bottleneck in Clinical Trials
Trials Are On The Clock In clinical research, time isn’t…